Press releases and news

clear
  • Prize-winning nanotechnology for biochips

    Press release / 4.11.2003

    Biochips have become the tool of choice for automating drug and protein screening. Sven Knecht was awarded the 3rd Hugo-Geiger Prize 2003 of the Fraunhofer-Gesellschaft for developing future methods of manufacturing biochips based on micro- and nano-technologies.

    more info
  • Hugo Geiger Prize 2003

    Fraunhofer IGB News / 1.11.2003

    Sven Knecht from Fraunhofer IGB was awarded the third Hugo Geiger Prize 2003 and the Procter & Gamble Sponsorship Prize 2003 for his thesis.

    more info
  • VPM GmbH, together with GBF, has licensed in its first project: a new, soluble beta-interferon that promises improved treatment of multiple sclerosis, the most common disease of the central nervous system. The substance was studied and developed in the laboratory by the Hannover-based Gene Technology Department of the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart.

    more info
  • Multiple sclerosis is one of the most common diseases of the central nervous system, treated successfully with the protein Interferon-beta. Researchers at Fraunhofer IGB have developed an improved Interferon-beta with enhanced solubility, bioavailability and pharmacokinetic stability. In June 2003, the US patent was granted, the European patent has been promised recently.

    more info
  • Max Buchner University Prize 2003

    Fraunhofer IGB News / 25.7.2003

    Max Buchner University Prize 2003

    Kathrin Zeller was awarded the 2003 Max Buchner Prize for her thesis work in using a resistance chip to show spot mutations of Candida albicans.

    more info
  • Optimized DNA chip for resistance research

    Press release / 18.7.2003

    Freqently, single nucleotide polymorphisms (SNPs) are responsible for the formation of resistances in pathogens. Researchers at Fraunhofer IGB have optimized a DNA chip, which enables the identification of such mutations in the ERG11 gene of the human pathogenic fungus Candida albicans.

    more info
  • Protein microchips can be used for the diagnosis of diseases. Researches at Fraunhofer IGB have developed a novel chip surface consisting of protein binding nanoparticles. These nanoparticles enable the direct enrichment and analysis by MALDI-TOF mass spectrometry.

    more info
  • Hugo Geiger Prize 2002

    Fraunhofer IGB News / 1.11.2002

    The first Hugo Geiger Prize 2002 of the Fraunhofer-Gesellschaft went to the up-and-coming biologist Marc Röhm from Fraunhofer IGB, the second to chemist Christian Schmalz.

    more info
  • Less sewage residues, more energy

    Press release / 26.8.2002

    The Fraunhofer IGB has developed a high-rate process for the digestion of sewage sludge. In the Heidelberg municipal sewage plant, it was integrated into the existing disposal line a year ago. This means that the plant can save costs, gain energy and at the same time has to dispose of less remaining organics.

    more info